Andrews William T. bought CPRX
June 3, 2026 · Form 4 insider transaction
Andrews William T. bought 3,052 shares of Catalyst Pharmaceuticals Inc, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,052
Price
N/A
Total value
N/A
InsiderAndrews William T.
Role—
SecurityCommon Stock, par value $0.001 per share
Transaction codeM: Option exercise
Transaction dateJune 3, 2026
Filing dateJune 5, 2026
Shares owned after3,052
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.